{
  "trial_id": "NCT03987919",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ethnicity, baseline HbA1c, duration of type 2 diabetes, body mass index (BMI), weight, fasting plasma glucose, blood pressure, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), estimated glomerular filtration rate (eGFR), liver function tests (ALT, AST), history of cardiovascular disease, use of antihypertensive medications, use of lipid-lowering medications, smoking status, physical activity level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1c",
          "baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of type 2 diabetes",
        "body mass index (BMI)",
        "weight",
        "fasting plasma glucose",
        "blood pressure",
        "lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides)",
        "estimated glomerular filtration rate (eGFR)",
        "liver function tests (ALT, AST)",
        "history of cardiovascular disease",
        "use of antihypertensive medications",
        "use of lipid-lowering medications",
        "smoking status",
        "physical activity level"
      ]
    },
    "processed-gen-response": "Age, gender, race, ethnicity, baseline HbA1c, duration of type 2 diabetes, body mass index (BMI), weight, fasting plasma glucose, blood pressure, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), estimated glomerular filtration rate (eGFR), liver function tests (ALT, AST), history of cardiovascular disease, use of antihypertensive medications, use of lipid-lowering medications, smoking status, physical activity level."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Body Mass Index, Duration of Diabetes, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR), Total Cholesterol, Triglycerides, Use of Antihypertensive Medication, Use of Lipid-lowering Medication,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Duration of Diabetes",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Total Cholesterol",
        "Triglycerides",
        "Use of Antihypertensive Medication",
        "Use of Lipid-lowering Medication"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline HbA1c, Body Mass Index, Duration of Diabetes, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR), Total Cholesterol, Triglycerides, Use of Antihypertensive Medication, Use of Lipid-lowering Medication"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Duration of Diabetes, Metformin Dose, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, eGFR, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Duration of Diabetes",
        "Metformin Dose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "eGFR",
        "History of Cardiovascular Disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, HbA1c, Duration of Diabetes, Metformin Dose, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, eGFR, History of Cardiovascular Disease."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at baseline, fasting plasma glucose at baseline, systolic blood pressure at baseline, diastolic blood pressure at baseline, heart rate at baseline, weight at baseline, metformin dose at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1c",
          "HbA1c at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose at baseline",
        "systolic blood pressure at baseline",
        "diastolic blood pressure at baseline",
        "heart rate at baseline",
        "weight at baseline",
        "metformin dose at baseline"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at baseline, fasting plasma glucose at baseline, systolic blood pressure at baseline, diastolic blood pressure at baseline, heart rate at baseline, weight at baseline, metformin dose at baseline."
  }
}